Quidel Corporation
QDEL
M
|
$38.28
-1.11%
-1.12%
1M
|
Health Technology
(0.0% 1d) (-20.0% 1m) (-57.3% 1y) (0.0% 2d) (-3.9% 3d) (-8.2% 7d) (-6.53% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 2,560,115,985
http://www.quidel.com
Sec Filling | Patents | 1250 employees
(US) Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.
molecular diagnostics diagnostics rapid diagnostics
add to watch list Paper trade email alert is off
Press-releases
QuidelOrtho To Report First Quarter 2024 Financial Results
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.06%
first report financial results
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-16 (Crawled : 04:00) - prnewswire.com
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -2.85%
H: 0.27%
C: -1.87%
CKPT | $1.595 -4.49% -4.7% 470K
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: -4.52%
QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay
Published: 2024-04-10 (Crawled : 12:30) - biospace.com/
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -2.64%
H: 2.3%
C: 1.24%
vitros partnership test assay
ROSEN, LEADING INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Inquire About Securities Class Action Investigation - QDEL
Published: 2024-04-03 (Crawled : 01:00) - prnewswire.com
LUXH | $0.901 -15.79% -18.76% 430K
|
|
| O: -0.71%
H: 2.86%
C: -2.86%
BCDRF | News | $4.978 -8.71% 100
|
Finance
|
| O: 3.9%
H: 4.33%
C: 4.33%
SAN | News | $4.75 1.93% -0.84% 3M
|
Finance
|
| O: 1.04%
H: 1.23%
C: 0.82%
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -0.17%
H: 1.57%
C: 1.07%
corporation
Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published: 2024-03-07 (Crawled : 00:00) - prnewswire.com
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: 1.14%
H: 4.36%
C: 3.16%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.1%
H: 0.18%
C: -1.25%
cancer treatment growth market
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
Published: 2024-03-06 (Crawled : 23:00) - biospace.com/
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: 0.14%
H: 0.91%
C: -0.3%
quidel test health approval canada
Global Respiratory Syncytial Virus Diagnostics Market Report 2024-2029: Rising Healthcare Expenditure, Technological Innovations, and Increased Incidence of RSV Fueling Growth
Published: 2024-03-05 (Crawled : 05:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.09%
H: 0.86%
C: 0.6%
DGX | $125.91 -0.84% -0.7% 870K
|
Health Services
|
| O: 0.38%
H: 0.69%
C: -1.01%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.32%
H: 0.22%
C: -0.2%
BIO | News | $281.02 -3.38% -0.36% 370K
|
Health Technology
|
| O: -0.53%
H: 1.08%
C: -0.59%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: 0.18%
H: 1.13%
C: -3.31%
report respiratory global rsv virus diagnostics growth market
Lateral Flow Assays Market Worth $16.8 billion | MarketsandMarkets™
Published: 2024-02-26 (Crawled : 15:30) - prnewswire.com
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: -0.55%
H: 0.08%
C: -0.36%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.13%
H: 0.38%
C: -0.68%
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -0.7%
H: 0.9%
C: -1.48%
flow market
QuidelOrtho Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-02-13 (Crawled : 00:00) - biospace.com/
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: -3.51%
H: 2.61%
C: -0.49%
financial results
QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
QDEL M | $38.28 -1.11% -1.12% 1M
|
Health Technology
|
| O: 1.23%
H: 0.19%
C: -1.34%
report financial results
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10